Received Sep 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | DD72H | — |
Bexsero instead of Boostrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 13-year-old male patient who received Men B NVS (Bexsero) (batch number DD72H, expiry date 30-NOV-2027) for prophylaxis. Co-suspect products included DTPa (Reduced antigen) (Boostrix) for prophylaxis. Concomitant products included meningococcal vaccine a/c/y/w conj (crm197) (Menveo). On 02-SEP-2025, the patient received the 1st dose of Bexsero. The patient did not receive Boostrix. On 02-SEP-2025, an unknown time after receiving Bexsero, the patient experienced wrong vaccine administered (Verbatim: Bexsero instead of Boostrix). The outcome of the wrong vaccine administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 03-SEP-2025 The Medical Assistant explained that on 2nd September 2025 they gave the wrong vaccine to a 13-year-old patient, since patient needed to get Boostrix, but they gave Bexsero instead. Also, caller mentioned that they gave Menveo (1-vial) on the same day. The Medical Assistant was not aware of prior Tetanus, Diphtheria or Pertussis vaccines, or Meningitis B vaccines for this patient.
MENVEO